Cipla Ltd. (CIPLA)

Date Range: 2026-03-22 to 2026-06-22 | Starting Capital: ₹100,000

Symbol-Specific Risk & Execution Parameters

These execution parameters have been optimized specifically for CIPLA based on historical volatility, structural character, and friction constraints:

• ATR Stop Distance (max_stop_atr): 1.50x ATR
• Minimum Reward-to-Risk Ratio (min_reward_risk): 1.20R
• Friction Buffer Target (friction_min_target_pct): 0.03%
• Positional Holds Allowed (allow_positional_hold): True

Executive Summary

Model Backtest & Validation Summary

To validate the conviction score recommendations, the system ran historical simulation backtests for CIPLA under institutional execution assumptions:

What Changed Since Previous Report?

• Initial Run / Baseline: No previous report was found for this symbol to perform comparative validation. This report establishes the baseline parameters.

Actionable Trading Guidance

Direct Stock Setup Outlook

No active intraday setup detected for the next session.

⌥ Options Strategy Recommendation

Recommended Vehicle: Cash Equity

Reason: Highest risk-adjusted return (EV/Risk Ratio of -0.084) with consistent historical expectancy and zero options friction.

• Volatility Dashboard: Realized Vol (RV): 20.9% | Implied Vol (IV): 22.2% | IV Rank: 38.5% | IV Percentile: 58.5%
• Directional Probabilities: P(up): 10% | P(down): 10% | P(flat): 80%
• Expected Return Distribution: Median: -0.61% (10th: -8.18%, 90th: +6.30%) | Expected Move: -0.00 ATR

Expected Value (EV) Payoff Matrix:

Systematic Execution Plan (Generic Framework)

• Stop Loss: 1.5 × ATR from entry
• Profit Targets: Target 1 (1R) for 50% scale-out, trail remainder.

Expected Outcomes & Suitability

Expected 1 Month Outcome

• Bullish: 10.0%
• Neutral: 80.0%
• Bearish: 10.0%

Expected Return Range

• Median: -0.61%
• 25th percentile: -3.92%
• 75th percentile: +2.70%

Portfolio Suitability

Suitable For:

• None

Not Suitable For:

• ✗ Swing Traders
• ✗ Positional Traders
• ✗ Long-Term Growth Investors
• ✗ Income Investors
• ✗ Low Volatility Portfolios
• ✗ Growth Investors

Sector & Regime Context

• Sector: Healthcare
• Sector Strength: 8.9/10
• Relative Strength: +0.25% vs NIFTY
• Sector Rank: 6 of 19 sectors
• Structural Regime: RANGE
• Tactical Setup Focus: Range Mean Reversion, Failed Breakout Reversal, Directional Change Overshoot, Bollinger Band Reversal, Volume Capitulation Reversal, PDH/PDL Breakout, Opening Gap Fade

Conviction Score Breakdown:

• 1. Technical Setups: +0.0 / 35 (No active technical setup and no strong daily momentum structure)
• 2. Fundamentals: +5.0 / 25 (Deteriorating business growth structure (Grade D))
• 3. Sector Context: +17.8 / 20 (Sector Strength: 8.9/10 (Healthcare))
• 4. Regime & Momentum: +10.8 / 20 (Daily candle close location: +0.8 pts (16% of range), Market in low-volatility/range regime RANGE: +5.0 pts, VIX is 13.5 (Low volatility/risk): +5.0 pts)

Conviction Rating System Matrix:

Fundamental Analysis & Annual Guidance

• Valuation: Trailing P/E: 30.4 | Forward P/E: 19.0 | PEG Ratio: N/A | Price/Book: 3.32
• Business Growth: Revenue YoY: -0.02% | Quarterly EPS: -0.55% | ROE: N/A
• Risk & Dividend: Beta: 0.12 | Dividend Yield: 0.92% | Book Value: 426.25
• Investment Grade: Grade D (Avoid)
• Recommendation: Revenue contraction signals structural business issues. High-stability defensive profile (Beta: 0.12).
• Annual Entry Guidance: No fresh capital allocation recommended.
• Annual Exit Guidance: Liquidate any existing holdings. A business with contracting revenue is mathematically a deteriorating asset.

Historical & Simulation Evidence

Model Validation: Capital Preservation (No Trades)

The system did not execute any trades during this backtest period. This is a valid risk-mitigation outcome: potential setups were systematically filtered out because they did not meet our strict expectation-to-risk constraints.

Data Status: Successfully analyzed 939433 minutes of price action.

Setup Status: Absolutely zero setups triggered mathematically.